Work

Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?

Year: 2023

Type: article

Source: Cancer Treatment Reviews

DOI: 10.1016/j.ctrv.2023.102569

Authors: Chiara Corti, Carmine De Angelis, Giampaolo Bianchini, Luca Malorni, Mario Giuliano, Erika Hamilton, Rinath Jeselsohn, Komal Jhaveri, Giuseppe Curigliano, Carmen Criscitiello

Institutions: University of Milan, European Institute of Oncology, Baylor College of Medicine, Federico II University Hospital, University of Naples Federico II, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Azienda Usl Toscana Centro, Hospital of Prato, Sarah Cannon, Tennessee Oncology, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367298925

FWCI: 9.113

Cites: 74

Cited by: 58

Related to: 10